Athens, GA – April 14, 2017
“Small Molecules for Understanding Life & Managing Disease”
The Southeastern Chemical Biology Symposium will take place Friday, April 14th at University of Georgia in Athens, Georgia. The conference will feature talks by faculty, post-doctoral scholars, graduate students, and undergraduate students selected from submitted abstracts. The symposium will include a poster session to facilitate discussion and collaborative interactions between scientists from all career stages. The keynote presentation will conclude the event.
Y. George Zheng
Keynote Speaker: Stuart Schreiber, Ph.D.
Stuart L. Schreiber, Ph.D. is the Director of the Center for the Science of Therapeutics and one of four founders of the Broad Institute, where he is a Howard Hughes Medical Institute Investigator. He is also the Morris Loeb Professor of Chemistry and Chemical Biology at Harvard University, and a member of the National Academy of Sciences.
Dr. Schreiber’s research integrates chemical biology and human biology to advance the science of therapeutics. He is known for having developed systematic ways to explore biology, especially disease biology, using small molecules and for his role in the development of the field of chemical biology. His work has contributed to diversity-oriented synthesis (DOS) and discovery-based small-molecule screening in an open data-sharing environment.
Schreiber extended chemical biology principles to medicine by participating in the founding of several biotech companies, including Vertex Pharmaceuticals, ARIAD Pharmaceuticals, Infinity Pharmaceuticals, Forma Therapeutics and H3 Biomedicine.